Clinical trial
Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing…
NCT00082121 · Avant Immunotherapeutics, Industry · Completed
Key facts
| NCT number | NCT00082121 |
|---|---|
| Title | Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery |
| Lead sponsor | Avant Immunotherapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia, Coronary Arteriosclerosis, Aortic Valve Insufficiency, Mitral Valve Insufficiency |
| Intervention type | Drug |
| Interventions | TP10 |
| Enrollment | 300 |
| Start date | Apr 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | May 4, 2004 |
| Last update posted | Jul 20, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: